Chemoocclusion vs chemoperfusion for treatment of advanced hepatocellular carcinoma: A randomised trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemoocclusion vs chemoperfusion for treatment of advanced hepatocellular carcinoma: A randomised trial

Published:2006-03 Issue:2 Volume:32 Page:201-207
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Kirchhoff T.D.,Rudolph K.L.,Layer G.,Chavan A.,Greten T.F.,Rosenthal H.,Kubicka S.,Galanski M.,Manns M.P.,Schild H.,Gallkowski U.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference35 articles.

1. Arterial chemoemboliation with microencapsulated anticancer drug. An approach to selective cancer chemotherapy with sustained effects;Kato;JAMA,1981

2. Changes in rat liver microcirculation after experimental hepatic arterial embolization: comparison of different embolic agents;Tancredi;Radiology,1999

3. Chemoembolization of hepatocellular carcinoma. A study of the biodistribution and pharmacokinetics of doxorubicin;Raoul;Cancer,1992

4. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma;N Engl J Med,1995

5. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution;Bruix;Hepatology,1998

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biodegradable Microspheres for Transarterial Chemoembolization in Malignant Liver Disease;Medicina;2024-04-22

2. Chemoembolization with Degradable Starch Microspheres (DSM-TACE): expanding indications in HCC multidisciplinary tumor board;Hepatoma Research;2023

3. Drugs for TACE of HCC;Transarterial Chemoembolization (TACE);2023

4. Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma;Biomedicines;2022-12-09

5. Limitations and Possibilities of Transarterial Chemotherapeutic Treatment of Hepatocellular Carcinoma;International Journal of Molecular Sciences;2021-12-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3